Provided by Tiger Trade Technology Pte. Ltd.

MetaVia Inc

1.79
-0.0300-1.65%
Pre-market: 1.820.0300+1.68%04:11 EST
Volume:121.74K
Turnover:222.53K
Market Cap:5.74M
PE:-0.16
High:1.89
Open:1.84
Low:1.78
Close:1.82
52wk High:23.10
52wk Low:1.66
Shares:3.21M
Float Shares:2.29M
Volume Ratio:0.28
T/O Rate:5.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3639
EPS(LYR):-39.1268
ROE:-168.18%
ROA:-58.41%
PB:0.91
PE(LYR):-0.05

Loading ...

Company Profile

Company Name:
MetaVia Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
9
Office Location:
545 Concord Avenue,Suite 210,Cambridge,Massachusetts,United States
Zip Code:
02138
Fax:
- -
Introduction:
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Hyung Heon Kim
Chief Executive Officer and Director and President
Andrew Koven
Chair of the Board and Director
D. Gordon Strickland
Director
James P. Tursi
Director
Jason L. Groves
Director
Mark A. Glickman
Director
Michael Salsbury
Director

Shareholders

Name
Position
Hyung Heon Kim
Chief Executive Officer and Director and President
Marshall H. Woodworth
Chief Financial Officer